Business · 10/06/1994Updated: 10/16/2026 · 1 min read
The Food and Drug Administration (FDA) Announces Public Workshop on Immunohistochemical Devices
Summary
The Food and Drug Administration (FDA) is hosting a public workshop to discuss the use of immunohistochemical devices in patient care and gathering comments on the regulation of immunohistochemical test products.
Original source language: Federal Register — Health and Human ServicesOpen original release →